a higher-dose version was shown to work as well as Wegovy, causing about 15 per cent weight loss. Several other weight-loss pills are also in late-stage trials, and if all goes smoothly, could be ...

The DASH diet was shown to lower blood pressure decades ago, yet few people follow it. Here’s how to give it a try.

Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...

Ozempic continues to surge in popularity for managing type 2 diabetes and off-label weight loss, but are there natural ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk ( NVO) and Eli Lilly ( LLY) by introducing GLP-1 pills.

Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.

Kourtney Kardashian is hopping on the weight loss trend with the launch of her new Lemme GLP-1 Daily capsules. The “Kardashians” star, 45, announced what are some are already referring to as ...

Gift 5 articles to anyone you choose each month when you subscribe. Ozempic maker Novo Nordisk says its highly anticipated experimental weight-loss pill Amycretin was safe and tolerable for ...

Amycretin’s phase 1 ... 6% weight loss after three months and 15% after 68 weeks. The Danish drugmaker said the findings are early, and more clinical trials remain. The obesity pill works ...

Share on Pinterest Novo Nordisk’s new weight loss pill ... orally as a pill rather than through a weekly injection. Like its counterparts, amycretin works by emulating the GLP-1 hormone that ...